Inventor · disambiguated record
Jens-Ulrich Rahfeld
Also filed as: RAHFELD JENS-ULRICH
19 granted patents·10 pending applications·61 citations·filing 2005–2023
91Inventor score
Files withPROBIODRUG AG16DEMUTH HANS-ULRICH3FRAUNHOFER GES FORSCHUNG3SCHILLING STEPHAN3CYNIS HOLGER1
Top patents by PatentIndex Score
29 records- 0192US8058405B2Antibodies specific for N-terminal truncated and pyroglutamate modified amyloid-beta peptidesDEMUTH HANS-ULRICH·Filed 2009·Granted Nov 15, 2011·38 cites·28 claims
- 0285US10603367B2Humanized antibodiesPROBIODRUG AG·Filed 2018·Granted Mar 31, 2020·2 cites·18 claims
- 0385US8129160B2Method of screening for inhibitors of glutaminyl cyclase activitySCHILLING STEPHAN·Filed 2009·Granted Mar 6, 2012·7 cites·19 claims
- 0481US8409837B2Crystal structure of glutaminyl cyclaseSCHILLING STEPHAN·Filed 2011·Granted Apr 2, 2013·5 cites·8 claims
- 0578US8889709B2Use of isoQC inhibitors in the treatment and prevention of inflammatory diseases or conditionsDEMUTH HANS-ULRICH·Filed 2009·Granted Nov 18, 2014·4 cites·37 claims
- 0674US7667044B2Compounds for the treatment of neurological disordersPROBIODRUG AG·Filed 2005·Granted Feb 23, 2010·2 cites·45 claims
- 0770US8647834B2Screening method for enzyme inhibitorsSCHILLING STEPHAN·Filed 2011·Granted Feb 11, 2014·2 cites·19 claims
- 0869US2010028918A1Glutaminyl cyclase as a diagnostic/prognostic indicator for neurodegenerative diseasesPROBIODRUG AG·Filed 2009·Application pending·0 cites
- 0967US11045533B2Humanized antibodiesPROBIODRUG AG·Filed 2020·Granted Jun 29, 2021·0 cites·18 claims
- 1061US8809508B2Diagnostic antibody assayKLEINSCHMIDT MARTIN·Filed 2012·Granted Aug 19, 2014·1 cites·10 claims
- 1160US2025163136A1Anti-transthyretin (ttr) binding proteins and uses thereofFRAUNHOFER GES FORSCHUNG·Filed 2023·Application pending·0 cites
- 1259US8518406B2Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (MCP-1 N1pE)CYNIS HOLGER·Filed 2009·Granted Aug 27, 2013·0 cites·26 claims
- 1359US2008249083A1Novel genes related to glutaminyl cyclasePROBIODRUG AG·Filed 2007·Application pending·0 cites
- 1457US9157918B2Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (MCP-1 N1pE)PROBIODRUG AG·Filed 2013·Granted Oct 13, 2015·0 cites·7 claims
- 1557US2017097365A1Glutaminyl cyclase as a diagnostic/prognostic indicator for neurodegenerative diseasesPROBIODRUG AG·Filed 2016·Application pending·0 cites
- 1654US9657089B2Diagnostic antibody assayPROBIODRUG AG·Filed 2014·Granted May 23, 2017·0 cites·20 claims
- 1754US8859250B2Crystal structure of glutaminyl cyclasePROBIODRUG AG·Filed 2013·Granted Oct 14, 2014·0 cites·13 claims
- 1853US2015247180A1Glutaminyl cyclase as a diagnostic/prognostic indicator for neurodegenerative diseasesPROBIODRUG AG·Filed 2015·Application pending·0 cites
- 1952US9156907B2Diagnostic antibody assayDEMUTH HANS-ULRICH·Filed 2011·Granted Oct 13, 2015·0 cites·50 claims
- 2051US2010099721A1Novel compounds for the treatment of neurological disordersPROBIODRUG AG·Filed 2009·Application pending·0 cites
- 2149US12043659B2Humanized and de-immunized antibodiesVIVORYON THERAPEUTICS N V·Filed 2019·Granted Jul 23, 2024·0 cites·14 claims
- 2248US9676843B2Uses of antibodies directed against amyloid-βPROBIODRUG AG·Filed 2015·Granted Jun 13, 2017·0 cites·26 claims
- 2346US2015361167A1Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (mcp-1 n1pe)PROBIODRUG AG·Filed 2015·Application pending·0 cites
- 2444US11703511B2Anti-isoAsp7 amyloid β (Aβ) antibodies and uses thereofFRAUNHOFER GES FORSCHUNG·Filed 2018·Granted Jul 18, 2023·0 cites·16 claims
- 2541US8741614B2Crystal structure of isoglutaminyl cyclaseSTEPHAN ANETT·Filed 2011·Granted Jun 3, 2014·0 cites·10 claims
- 2640US2011166035A1Novel diagnostic methodPROBIODRUG AG·Filed 2010·Application pending·0 cites
- 2738US2017363645A1Novel Method for the Detection of pGlu-Abeta PeptidesPROBIODRUG AG·Filed 2015·Application pending·0 cites
- 2837US11186572B2Bacterial glutaminyl cyclases and inhibitors thereof for use in the treatment of periodontitisFRAUNHOFER GES FORSCHUNG·Filed 2017·Granted Nov 30, 2021·0 cites·20 claims
- 2936US2011212853A1Novel diagnostic methodPROBIODRUG AG·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →